| | | |

Cosmetic Talc Can Cause Mesothelioma, Study Finds

cosmetic talc can cause mesothelioma

A new study in the American Journal of Industrial Medicine appears to offer definitive evidence that repeated exposure to cosmetic talc can cause mesothelioma. 

It is an issue that has come up repeatedly in courtrooms in recent years. Lawyers for mesothelioma patients who have used cosmetic talc say the products are unsafe. Manufacturers like Johnson & Johnson insist they are pure. 

But the new study shows that may not be the case. If the product is contaminated with asbestos, as many appear to be, the study shows cosmetic talc can cause mesothelioma. 

How Can Cosmetic Talc Cause Mesothelioma?

Talcum powder is made from talc, which contains magnesium and silicon. Because it absorbs moisture, people use it to keep skin dry and prevent rashes from friction. Some animal studies on pure talc have suggested it can cause tumors. But the International Agency for Research on Cancer (IARC) does not classify it as a known carcinogen. 

The bigger problem is asbestos, which is known to cause cancer. Deposits of talc and asbestos lie close together in the ground. Cosmetic talc can cause mesothelioma because some of it contains small amounts of asbestos. 

When asbestos fibers get into the body, they never leave. They can trigger malignant mesothelioma even years after exposure. The longer a person is exposed to asbestos, the more likely they are to receive a mesothelioma diagnosis. 

Asbestos-Tainted Talc and Mesothelioma

Researchers interviewed 140 people with documented exposure to cosmetic talc. They chose 75 to be part of the new study on whether cosmetic talc can cause mesothelioma. Sixty-four of the patients were men and 11 were women. All had confirmed cases of malignant mesothelioma. 

Scientists cannot be sure the exact concentration of the talc these people encountered. But they do know that the study participants had an average of 33 years of exposure to cosmetic talc. None of them lived or worked around asbestos, so the talc was their only known exposure. 

Malignant mesothelioma usually occurs in older people, but 16 percent of the study subjects were younger than 45. Forty-eight people had pleural mesothelioma, 23 had peritoneal mesothelioma, and two patients had both kinds. One person had testicular mesothelioma and another had it around their heart, called pericardial mesothelioma. 

In eleven cases, scientists examined their tissue under high-end microscopes for signs of asbestos fibers. 

Results of the Latest Talc Study

“Of the 11 individuals whose nontumorous tissues were analyzed for the presence of asbestiform fibers, all showed the presence of anthophyllite and/or tremolite asbestos,” writes lead author and pathologist Theresa Emory, MD

This suggests that there was definitely asbestos in their talcum powder and that cosmetic talc can cause mesothelioma. The findings may help with current and future legal cases against cosmetic talc producers.

Dr. Emory and her colleagues conclude, “Mesotheliomas can develop following exposures to cosmetic talcum powders. These appear to be attributable to the presence of anthophyllite and tremolite contaminants in cosmetic talcum powder.”

Sources:

Emory, TS, et al, “Malignant mesothelioma following repeated exposures to cosmetic talc: A case series of 75 patients”, March 16, 2020, American Journal of Industrial Medicine, Epub ahead of print, https://onlinelibrary.wiley.com/doi/full/10.1002/ajim.23106\

Talcum Powder and Cancer, American Cancer Society website, Accessed March 21, 2020, https://www.cancer.org/cancer/cancer-causes/talcum-powder-and-cancer.html

Similar Posts

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • |

    Mesothelioma Victims’ Victory in Pennsylvania

    Workers and their families have won a victory in Pennsylvania after the state Supreme Court ruled that they could sue former employers over late-manifesting industrial diseases like mesothelioma. The decision focused on a provision in Pennsylvania’s Workers’ Compensation Act that says workers cannot sue an employer if their occupational disease occurred more than 300 weeks after their on-the-job exposure. While many occupational injuries and diseases occur within weeks or months of exposure to a toxin, asbestos diseases like mesothelioma are a notable exception. Believed to be caused by chronic irritation from inhaled or ingested asbestos fibers, mesothelioma does not usually begin to cause symptoms until at least a decade after exposure. Expressing the opinion of the majority, Supreme Court Justice…

  • | |

    Micro-RNAs May Offer New Way to Fight Mesothelioma

    Scientists at one of the world’s top mesothelioma research centers, the Asbestos Diseases Research institute in Sydney, Australia, say that restoring the expression of certain micro RNAs in the cells of mesothelioma patients may offer a new way to fight the disease. A microRNA is a small RNA molecule which is involved in the regulation of gene expression. According to a new report in the Annals of Oncology, the Australian scientists found reduced expression of the micro RNA-15 family (miR-15/16) in the cells of mice with mesothelioma. “When malignant pleural mesothelioma cell lines were compared with the normal mesothelial cell line MeT-5A, the downregulation of miR-15/16 was 2- to 10-fold,” they report. This finding is consistent with previous cancer research…

  • |

    Last Man Sentenced in Asbestos Dumping Scheme

    The U.S. Justice Department has announced that a New Jersey man will spend 15 months in prison for his part in a scheme to illegally dump thousands of tons of asbestos-contaminated construction debris – putting others at risk for mesothelioma. He was the last person to be sentenced in the conspiracy. Asbestos is the cause of mesothelioma, a difficult to treat and aggressive cancer.  At the height of its popularity from the 1940s to the early 1970s, asbestos was common in building products ranging from floor and ceiling tiles to joint compound, concrete and shingles. It is still present in tens of thousands of older homes and buildings today. In an effort to protect workers and the public from mesothelioma…

  • |

    Mesothelioma Case Shows Danger of Accidental Asbestos Exposure

    A mesothelioma case in Birmingham, England is a dramatic illustration of the very real danger of hidden asbestos. The widow of a physician who died of mesothelioma last year at the age of 51 claims her husband was exposed to asbestos just walking to and from his medical classes. Monisha Coelho believes that exposed asbestos insulation in the underground hallways that connect the University of Birmingham to buildings on the Queen Elizabeth Hospital campus triggered Dr. Ian Pardoe’s mesothelioma. In an article in the Birmingham Mail, Coelho explained how her husband decided how and where the deadly exposure had occurred. “Ian thought long and hard about where he might have come into contact with asbestos,” Coelho told the paper. “He…

  • | |

    Treatment Uses Herpes Virus to Shrink Mesothelioma Tumors

    Researchers at a hospital in Sheffield, England are testing a potential new mesothelioma treatment based on the same virus that causes herpes. The small-scale trial is the first in the world to test the modified herpes simplex virus, HSV1716, in human mesothelioma patients. HSV1716 has been genetically engineered to infect and kill cancer cells without harming healthy cells. In laboratory studies on mesothelioma and some other cancers, it has been shown to be effective at shrinking tumors while causing limited toxicity. Just as significantly, HSV1716 increased survival rates among mice with various human cancers. The Phase I/II trial at Sheffield Experimental Cancer Medicine Centre is the next stage in development of HSV1716 as a viable mesothelioma treatment. The goal of…